Treatment of GI cancer Flashcards
First line treatment for gastroesophageal cancer
IV 5-FU or PO capecitabine
Fluorouracil based chemotherapy
Alternative treatments for gastroesophageal cancer
Cisplatin based regimens
Combined with either irinotecan or a taxane
Treatment for metastatic gastroesophageal cancer with overexpression of HER-2/neu receptor
Trastuzumab and cisplatin
Treatment of metastatic pancreatic cancer
Gemcitabine
Treatment of hepatocellular cancer
Sorafenib
Curative modality for localized colon cancer
Surgical removal/colectomy
Adjuvant chemotherapy for colon cancer for 6 mos after surgery
Oxaliplatin with 5-FU and leucovorin
Cytotoxic agent that is an analog of thymine and works by blocking DNA synthesis by inhibiting DNA polymerase and being incorporated into nascent DNA, causing chain termination.
Fluorouracil
Capecitabine (prodrug)
Uses of fluorouracil
Breast ca
Colorectal ca
Gastric ca
SCC of head and neck
Uses of capecitabine
Colorectal ca
Breast ca
Uses of oxaliplatin
Pancreatic ca
Colorectal ca
Gastroesophageal ca
Mechanism of irinotecan
Inhibits topoisomerase I
When is irinotecan used in colorectal ca?
Used in recurrence, or in progression after 5-FU therapy
Anti-VEGF monoclonal antibody used for treating metastatic colon ca
Bevacizumab
Adverse effects of bevacizumab
HTN
Increased thomboembolic events
Slowed wound healing
GI perforations
Proteinuria
Anti-EGFR monoclonal antibodies used in treating metastatic colorectal ca expressing KRAS or NRAS
Cetuximab
Panitumumab
Adverse effects of cetuximab and panitumumab
Acneiform skin rash
Hypersensitivity infusion reaction
Hypomagnesemia
Fusion protein that target VEGF-A, VEGF-B, and PIGF. Used for colorectal ca
Ziv-aflibercept
Anti-VEGF-R2 antibody used for colorectal ca.
Ramucirumab
Small molecule tyrosine kinase inhibitor used for colorectal ca
Regorafenib
Symptoms of carcinoid syndrome
Flushing
Abd pain
Diarrhea
Bronchoconstriction
Carcinoid heart disease
Cause of carcinoid syndrome
Release of vasoactive amines into the systemic ciruclation
Only potential curative therapy for GI carcinoid tumors
Surgical resection
Slow-growing GI tumors that originate in the neuroendocrine cells
Carcinoid tumors
Short-acting somatostatin analog used in GI carcinoid tumors
Octreotide
Long-acting somatostatin analog used in GI carcinoid tumors
Lanreotide
Effect of somatostatin analogs in GI carcinoid tumors
Treat carcinoid syndrome by cAMP inhibition
Drug used for inhibition of disease progression and symptom relief in GI carcinoid tumors
Interferon alpha